We sought to re-examine the importance of DNA clearance in the pathogenesis of lupus by engineering a long-acting, bioavailable, glycopolished enzyme biologic with dual DNASE1/DNASE1L3 activity for use in murine models of lupus. The gene discussed is DNASE1; the disease is systemic lupus erythematosus.